发明名称 |
PHARMACEUTICALLY ACCEPTABLE SALTS OF 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS |
摘要 |
Provided herein are pharmaceutically acceptable salts of 3,5-diaminopyrazoles, for example, pharmaceutically acceptable salts of compounds of Formula IA, that are useful for modulating regulated-in-COPD kinase activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a RC kinase-mediated disorder, disease, or condition. |
申请公布号 |
EP3046918(A1) |
申请公布日期 |
2016.07.27 |
申请号 |
EP20140786388 |
申请日期 |
2014.09.17 |
申请人 |
AXIKIN PHARMACEUTICALS, INC. |
发明人 |
LY, TAI, WEI;RAAUM, ERIK, DEAN |
分类号 |
C07D403/12;A61K31/4155;A61P11/06;A61P37/08;C07D231/38;C07D401/12 |
主分类号 |
C07D403/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|